BNOEF

Bionomics Ltd.

 
Ordinary Shares International Reporting
OTCQX International
Verified Company Profile 12/05/2016
Contact Info
  • 31 Dalgleish Street
  • Thebarton, SA 5031
  • Australia

Business Description


 
Financial Reporting/Disclosure
Reporting Status International Reporting: ASX - Australian Securities Exchange
Audited Financials Audited
Latest Report Dec 31, 2016 Quarterly Report
CIK 0001194833
Fiscal Year End 6/30
OTC Marketplace OTCQX International
Profile Data
SIC - Industry Classification 2836 - Biological products, except diagnostic
Incorporated In: South Australia, Australia
Year of Inc. 1996
Employees 64 a/o Jun 30, 2014
Company Officers/Contacts
Deborah Rathjen CEO
Melanie Young CFO
Jack Moschakis Legal Counsel, Company Secretary Manager
Company Directors
Errol De Souza Chairman
Alan Fisher
Deborah Rathjen
Peter Turner
David Wilson
Service Providers
Accounting/Auditing Firm
Deloitte Touche Tohmatsu
Woodside Plaza Level 14
240 St Georges Tce
Perth, WA, 6000
Australia
 
Securities Counsel
Johnson Winter & Slattery
Level 9
211 Victoria Square
Adelaide, SA, 5000
Australia
 
Investor Relations Firm
Stern IR, Inc.
19 West 87th Street
Suite 400
New York, NY, 5000
United States
 
Company History
  • Sponsored for OTCQX by Cowen and Company, LLC on 3/2/2015.
BNOEF Security Details
Share Structure
Market Value1 $130,400,443 a/o Mar 24, 2017
Authorized Shares 481,182,446 a/o Oct 05, 2016
Outstanding Shares 481,182,446 a/o Oct 05, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value No Par Value
Transfer Agent(s)
Shareholders
Shareholders of Record Not Available
Non US Stock Exchange Listing
BNO - ASX - Australian Securities Exchange - Qualified
Short Selling Data
Short Interest 25,116 (100%)
Feb 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security